FDAFDA · Food and drugs·Recall number D-0728-2026
Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01
Published July 29, 2026 · Recall initiated: July 16, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Hair was found in products
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- XYLOCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide within in the USA
- UPC
- 0363323484576
- Lot
- Lot #: 6130235, Exp. Date 02/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.